Next-generation sequencing (NGS) plays an important role in cancer diagnostics. Creative Biolabs offers SuPrecision™ Platform covering a full range of NGS-based services. This tool greatly improves our understanding of the multifaceted disease and achieves accurate, sensitive, high-throughput and cost effective cancer detection.

1. Next-generation sequencing
(NGS) technologies have
progressive advantages in
terms of cost-effectiveness,
unprecedented sequencing
speed, high resolution and
accuracy in genomic analy-
ses, thus are playing an
increasing important role in
fields of oncology and immu-
nology.
The sequencing principles of
common sequencing instru-
ments on the market: (1) first,
construct a DNA template
library. Obtain DNA library
fragments (tens to hundreds
of bases in length) by
randomly breaking genomic
DNA, or construct paired-end
fragments that control the
distance distribution. Adapter
sequences were ligated to
both ends of the DNA
fragment and then denatured
to obtain a single-stranded
template library and immobi-
lized on a solid surface. (2)
Second, amplify the clones,
which performed by one of
several methods, such as
bridge PCR and emulsion
PCR. (3) Then, forming DNA
clusters or amplifying micro-
spheres of DNA cluster arrays
on a chip, performing a series
of cyclic reaction operations
using a polymerase or ligase,
and monitoring the optical
events generated in each
cycle biochemical reaction by
a microscopic detection syst-
em. Time series analysis of
the resulting array images is
performed to obtain sequenc-
es of DNA fragments. These
fragments are then assem-
bled into longer contigs
according to certain computer
algorithms.
Creative Biolabs uses the
advanced SuPrecision™ pl-
atform to support researchers
all over the world with their
sequencing needs for cancer.
NEXT GENERATION
SEQUENCING SERVICE
Creative Biolabs
Next Generation
Sequencing
Service
© 2007 - 2019 Creative-Biolabs All Rights Reserved Email: info@creative-biolabs.com Tel: 1-631-381-2994
WHAT WE DO:
Whole Genome Sequencing (WGS)
Service for Cancer
Whole Exome Sequencing (WES)
Service for Cancer
Targeted Sequencing Service for
Cancer
Whole Transcriptome Sequencing (WTS)
Service for Cancer
Immune Repertoire Sequencing (Rep-seq)
Service for Cancer
Bioinformatics Analysis Service

2. DNA Library Preparation
1 Clonal Amplification
2
Cyclic Array Sequencing
3
T
5'
5'
3'
3'
T
5'
3'
T
C
A
A
A n
A n z
n z
z
C G T
T
5'
3'
A
A
T
5'
3'
A
G
A
A
A
A
A
T
5'
3'
A
A
A
A

3. 1
4 5
2 3
A
C
G
T
5'
3'
A n
G n z
n z
z
5'
5'
3'
A n
T n z
n z
z
3'
3'
T
n
C
A
G
n z
n
z
z
n
A
C n z
n z
5'
3'
A n
C n z
n z
z

4. 
3'
3'
T
n
C
A
G n
n
z
z z
3'
3'
T
C T
G
A
G
A
C
3'
3'
T
C T
G
A
G
A
C
T
C T
T
T
G
G
T
A
A
G A
A
A
T
C
C
C
C
T
GG A
G
A
T